Medicines Co (MDCO) Tops Q1 EPS by 13c

Medicines Co (NASDAQ: MDCO) reported Q1 EPS of $0.27, $0.13 better than the analyst estimate of $0.14. Revenue for the quarter came in at $126.6 million versus the consensus estimate of $123.99 million.

For earnings history and earnings-related data on Medicines Co (MDCO) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c